These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16045546)

  • 1. Hyperproduction of fibrin and inefficacy of antithrombin III and alpha2 macroglobulin in the presence of bacterial porins.
    Di Micco B; Di Micco P; Lepretti M; Stiuso P; Donnarumma G; Iovene MR; Capasso R; Tufano MA
    Int J Exp Pathol; 2005 Aug; 86(4):241-5. PubMed ID: 16045546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porins from Salmonella typhimurium accelerate human blood coagulation in vitro by selective stimulation of thrombin activity: implications in septic shock DIC pathogenesis.
    Di Micco B; Metafora S; Colonna G; Cartenì M; Ragone R; Macalello MA; Di Micco P; Baroni A; Catalanotti P; Tufano MA
    J Endotoxin Res; 2001; 7(3):211-7. PubMed ID: 11581572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the inhibition of thrombin by three plasma protease inhibitors.
    Downing MR; Bloom JW; Mann KG
    Biochemistry; 1978 Jun; 17(13):2649-53. PubMed ID: 79421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of antithrombin III, alpha 2 macroglobulin and alpha 1 antitrypsin in progressive antithrombin activity of human plasma.
    Lebreton de Vonne T; Mouray H
    Int J Biochem; 1980; 12(3):479-84. PubMed ID: 6158467
    [No Abstract]   [Full Text] [Related]  

  • 5. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B; Griffin JH
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
    Gram J
    Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new assay for the measurement of total progressive antithrombin.
    Lane JL; Bird P; Rizza CR
    Br J Haematol; 1975 May; 30(1):103-15. PubMed ID: 53064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. alpha-Thrombin within fibrin clots: inactivation of thrombin by antithrombin-III.
    Naski MC; Shafer JA
    Thromb Res; 1993 Mar; 69(5):453-65. PubMed ID: 8497860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble fibrin complexes and fibrinogen heterogeneity in diabetes mellitus.
    Tsianos EB; Stathakis NE
    Thromb Haemost; 1980 Dec; 44(3):130-4. PubMed ID: 6162208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioregulatory roles for fibrin(ogen) on blood coagulation.
    Okwusidi JI; Ofosu FA
    Med Hypotheses; 1992 Oct; 39(2):152-5. PubMed ID: 1461178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha 2-Macroglobulin remains as important as antithrombin III for thrombin regulation in cord plasma in the presence of endothelial cell surfaces.
    Ling X; Delorme M; Berry L; Ofosu F; Mitchell L; Paes B; Andrew M
    Pediatr Res; 1995 Mar; 37(3):373-8. PubMed ID: 7540283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo catabolism of alpha 1-proteinase inhibitor-trypsin, antithrombin III-thrombin and alpha 2-macroglobulin-methylamine.
    Fuchs HE; Shifman MA; Pizzo SV
    Biochim Biophys Acta; 1982 May; 716(2):151-7. PubMed ID: 6178438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of fibrin(ogen) on thrombin generation and decay.
    Kremers RM; Wagenvoord RJ; Hemker HC
    Thromb Haemost; 2014 Sep; 112(3):486-94. PubMed ID: 24964786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood coagulation after long distance running: antithrombin III prevents fibrin formation.
    Bärtsch P; Haeberli A; Straub PW
    Thromb Haemost; 1990 Jun; 63(3):430-4. PubMed ID: 2402746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A kinetic model for the alpha-thrombin-catalyzed conversion of plasma levels of fibrinogen to fibrin in the presence of antithrombin III.
    Naski MC; Shafer JA
    J Biol Chem; 1991 Jul; 266(20):13003-10. PubMed ID: 2071587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: implications for heparin efficacy.
    Hogg PJ; Jackson CM
    Proc Natl Acad Sci U S A; 1989 May; 86(10):3619-23. PubMed ID: 2726739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dextran sulphates on thrombin activity.
    Suzuki K; Hashimoto S
    J Clin Pathol; 1979 May; 32(5):439-44. PubMed ID: 469001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation protein function V: diminution of antithrombin III function by acetaldehyde.
    Brecher AS; Hellman K; Dulin C; Basista MH
    Dig Dis Sci; 1998 Aug; 43(8):1746-51. PubMed ID: 9724163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma coagulation proteases, proteolytic inhibitors, and their interaction with platelets.
    Rao AK; Schmaier AH; Colman RW
    Pathobiol Annu; 1982; 12():35-64. PubMed ID: 6186978
    [No Abstract]   [Full Text] [Related]  

  • 20. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6.
    Kruithof EK; Mestries JC; Gascon MP; Ythier A
    Thromb Haemost; 1997 May; 77(5):905-10. PubMed ID: 9184401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.